Eli Lilly, the pharmaceutical company behind GLP-1 injection Zepbound, is working to bring its weight loss drug to the market in pill form. In an Aug. 7 earnings call, Eli Lilly C ...

Recently released results from a clinical trial on orforglipron show that the oral medication can cause impressive weight ...